This post was originally published on this site
J&J announced earnings per share of $2.59 on revenue of $24.02B. Analysts polled by Investing.com anticipated EPS of $2.55 on revenue of $23.8B.
J&J shares are up 1% from the beginning of the year, still down 6.67% from its 52 week high of $186.69 set on April 25. They are outperforming the S&P Global 100 which is down 17.22% from the start of the year.
J&J’s report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
Novartis ADR had beat expectations on Tuesday with second quarter EPS of $1.56 on revenue of $12.78B, compared to forecast for EPS of $1.52 on revenue of $12.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
